Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135440) titled 'The Potential of Optical Coherence Tomography Angiography (OCTA) to Detect Early Cognitive Dysfunction in Diabetic Patients' on Aug. 1.

Study Type: Observational

Primary Sponsor: Dr. Sefic Eye Polylcinic and Optical Studio

Condition: Type 2 Diabetes Mellitus Diabetic Retinopathy Cognitive Dysfunction

Intervention: Device: OCT angiography RTVue XR Avanti

Recruitment Status: Not recruiting

Date of First Enrollment: November 1, 2024

Target Sample Size: 210

Countries of Recruitment: Bosnia and Herzegovina

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07135440

Published by HT Digital Content Serv...